Mario Pirisi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Mario Pirisi

Showing results (221-230 of 236) with videos related to

Pageof 24

Sort By:

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 12, 2020

Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational studyAlessio Aghemo, Alfredo Alberti, Pietro Andreone, et al.

Scientific Reports|November 23, 2021

Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19Mattia Bellan, Alessio Baricich, Filippo Patrucco, et al.

JHEP Reports : Innovation in Hepatology|December 1, 2025

Lenvatinib <i>vs.</i> sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN studyPasquale Lombardi, Jung Sun Kim, Giulia F Manfredi, et al.

Hepatology (Baltimore, Md.)|November 8, 2019

Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based ApproachGuohong Han, Sarah Berhane, Hidenori Toyoda, et al.

ERJ Open Research|February 2, 2021

Outcomes of COVID-19 patients treated with continuous positive airway pressure outside the intensive care unitRosanna Vaschetto, Francesco Barone-Adesi, Fabrizio Racca, et al.

Cancers|July 12, 2020

Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in EuropeDavid J Pinato, Alvin J X Lee, Federica Biello, et al.

JAMA Network Open|January 27, 2021

Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital DischargeMattia Bellan, Daniele Soddu, Piero Emilio Balbo, et al.

European Journal of Cancer (Oxford, England : 1990)|April 24, 2026

Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinomaPei-Chang Lee, Alessio Cortellini, Bernardo Stefanini, et al.

Nutrients|March 11, 2023

Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical TrialErica Matino, Elena Tavella, Manuela Rizzi, et al.

JAMA Oncology|July 18, 2024

Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B DysfunctionClaudia Angela Maria Fulgenzi, Bernhard Scheiner, Antonio D'Alessio, et al.

Pageof 24

Search research articles

Showing results (221-230 of 236) with videos related to

Sort By:

Pageof 24

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 12, 2020

Scientific Reports|November 23, 2021

Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19Mattia Bellan, Alessio Baricich, Filippo Patrucco, et al.

JHEP Reports : Innovation in Hepatology|December 1, 2025

Lenvatinib <i>vs.</i> sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN studyPasquale Lombardi, Jung Sun Kim, Giulia F Manfredi, et al.

Hepatology (Baltimore, Md.)|November 8, 2019

Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based ApproachGuohong Han, Sarah Berhane, Hidenori Toyoda, et al.

ERJ Open Research|February 2, 2021

Outcomes of COVID-19 patients treated with continuous positive airway pressure outside the intensive care unitRosanna Vaschetto, Francesco Barone-Adesi, Fabrizio Racca, et al.

Cancers|July 12, 2020

Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in EuropeDavid J Pinato, Alvin J X Lee, Federica Biello, et al.

JAMA Network Open|January 27, 2021

Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital DischargeMattia Bellan, Daniele Soddu, Piero Emilio Balbo, et al.